NPCE

NeuroPace, Inc. [NPCE] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

NPCE Stock Summary

Top 10 Correlated ETFs

NPCE

Top 10 Correlated Stocks

NPCE

In the News

NPCE Financial details

Company Rating
-
Market Cap
382.65M
Income
-36.98M
Revenue
65.42M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
171
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
-7.93
Forward P/E
-
PEG
2.36
P/S
5.75
P/B
20.94
P/C
-
P/FCF
-14.16
Quick Ratio
5.67
Current Ratio
6.55
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.44
EPS next Y
-
EPS next Q
-
EPS this Y
-41.47%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-5.78%
Revenue last 5Y
12.09%
Revenue Q/Q
9.65%
EPS Q/Q
-17.86%
-
-
-
-
SMA20
-10.18%
SMA50
-12.28%
SMA100
6.36%
Inst Own
-
Inst Trans
-
ROA
-44%
ROE
-173%
ROC
-0.37%
Gross Margin
72%
Oper. Margin
-53%
Profit Margin
-72%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.795-18.15
52W High
-35.06%
52W Low
+289.67%
RSI
52.37
Rel Volume
1.05
Avg Volume
103.92K
Volume
108.61K
Perf Week
10.91%
Perf Month
2.54%
Perf Quarter
83.52%
Perf Half Y
83.23%
-
-
-
-
Beta
2.09
-
-
Volatility
0.38%, 0.85%
Prev Close
-2.42%
Price
11.69
Change
0.69%

Something similar

Top by Market Cap
FXAIX
TSLA
EMBASSY.NS
AAPL
V
Top Correlated ETFs
RCD
LTPZ
AGGH
USTB
RIFI.TO
Top Correlated Stocks
MBX.TO
HLF
CVEO
PBPB
PRAA
Similar Market Cap
FDT
M12.DE
BLZE
PWFL
VETN.SW

Company Profile

Healthcare Medical - Devices
  • Volume Average 103.92K
  • Market Capitalization 382.65M
  • Employee 171
  • CEO Mr. Joel D. Becker
  • Headquarters Mountain View,CA,US
  • IPO Date 2021-04-22
  • Website https://www.neuropace.com

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.